$3.79 $0.03 (0.8%)

04:30 PM EDT on 05/17/19

Catalyst Pharm Partners Inc (NASDAQ:CPRX)

CAPS Rating: 2 out of 5

A development-stage pharmaceutical company focused on the acquisition, development and commercialization of prescription drugs for the treatment of drug addiction.

Current Price $3.79 Mkt Cap $555.1M
Open $3.76 P/E Ratio 0.00
Prev. Close $3.76 Div. (Yield) $0.00 (0.0%)
Daily Range $3.68 - $3.84 Volume 497,967
52-Wk Range $1.85 - $6.16 Avg. Daily Vol.

Caps

How do you think NASDAQ:CPRX will perform against the market?

Add Stock to CAPS Watchlist

All Players

62 Outperform
15 Underperform
 

All-Star Players

7 Outperform
3 Underperform
 

Wall Street

3 Outperform
0 Underperform
 

Top NASDAQ:CPRX Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

zzlangerhans (99.80)
Submitted July 07, 2016

Catalyst has taken some serious body blows this year and things could certainly get worse before they get better. The market hasn't been kind to wounded microchip biotech without a clearly defined upcoming catalyst. Nevertheless, I think it's more… More

zzlangerhans (99.80)
Submitted June 01, 2013

Why did a huge, successful company like Biomarin outlicense the US rights to their developmental drug Firdapse for Lambert-Eaton Syndrome to a tiny, sketchy biopharma like Catalyst? I have to admit I have no idea, but I find the recent run in… More

NASDAQ:CPRX VS S&P 500 (SPY)

Fools bullish on NASDAQ:CPRX are also bullish on:

Fools bearish on NASDAQ:CPRX are also bearish on:

Recent Community Commentary

Read the most recent pitches from players about CPRX.

Recs

0
Member Avatar OklaBoston (42.01) Submitted: 5/9/2019 7:33:17 AM : Outperform Start Price: $3.69 NASDAQ:CPRX Score: +2.45

Senior officer open market purchases in 2018 primarily.

Recs

0
Member Avatar mrbill6 (< 20) Submitted: 4/26/2019 9:47:04 PM : Outperform Start Price: $6.01 NASDAQ:CPRX Score: -34.37

Barchart Top 100

Recs

2
Member Avatar zzlangerhans (99.80) Submitted: 7/7/2016 12:38:01 AM : Outperform Start Price: $0.74 NASDAQ:CPRX Score: +374.15

Catalyst has taken some serious body blows this year and things could certainly get worse before they get better. The market hasn't been kind to wounded microchip biotech without a clearly defined upcoming catalyst. Nevertheless, I think it's more likely that the stock moves upward than downward from here as the company prepares to initiate a confirmatory phase III trial of Firdapse for LEMS. The prize is still within reach and management has affirmed no intention of raising cash prior to acceptance of their next NDA submission. I'm not a fan of the company and I haven't had a good record buying in this kind of situation so no real money here.

Leaderboard

Find the members with the highest scoring picks in CPRX.

Score Leader

trackaegiscorp

trackaegiscorp (38.12) Score: +605.53

The Score Leader is the player with the highest score across all their picks in CPRX.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
Encontrado 50.50 1/7/2013 Outperform 5Y $0.51 +650.50% +96.31% +554.18 0 Comment
tehpirateguy 58.66 3/15/2013 Outperform 3M $0.54 +607.75% +83.83% +523.92 0 Comment
MrTwo94 86.82 11/8/2012 Outperform 1Y $0.58 +558.44% +104.57% +453.87 0 Comment
htsigns < 20 11/8/2012 Outperform 5Y $0.59 +547.75% +105.06% +442.70 0 Comment
lfreefall < 20 11/8/2012 Outperform 5Y $0.64 +492.28% +103.94% +388.34 0 Comment
flypower 98.43 8/2/2016 Outperform 5Y $0.73 +419.18% +32.67% +386.51 0 Comment
zzlangerhans 99.80 7/6/2016 Outperform 1Y $0.74 +411.95% +37.80% +374.15 1 Comment
bltone < 20 5/3/2013 Outperform 3Y $0.83 +357.18% +77.47% +279.71 0 Comment
dreamyy 35.43 10/27/2016 Outperform 5Y $1.07 +254.21% +33.27% +220.94 0 Comment
Under5 < 20 2/6/2017 Outperform 5Y $1.13 +235.40% +24.95% +210.45 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

Player Name Player
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
S&P
Gain
Score End Date Commentary
TrackPiperJaff 85.94 10/5/2016 Outperform NS $1.28 +196.09% +32.76% +163.34 0 Comment
TrackMaximGroup 64.25 9/24/2013 Outperform NS $2.96 +28.04% +68.32% -40.28 0 Comment
trackaegiscorp 38.12 4/18/2013 Outperform NS $0.48 +689.58% +84.06% +605.53 0 Comment
TrackZacks < 20 9/22/2010 Outperform 3M $1.16 -62.50% +21.81% -84.31 11/9/2012 @ $0.44 1 Comment

Advertisement